Paraproteinaemia after allo-SCT, association with alemtuzumab-based conditioning and CMV reactivation
P. Medd, S. Littlewood, R. Danby, R. Malladi, R. Clifford, D. Wareham, K. Jeffery, B. Ferry, D. Roberts, A. Peniket, T. Littlewood*
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
8Citations
(Scopus)
Fingerprint
Dive into the research topics of 'Paraproteinaemia after allo-SCT, association with alemtuzumab-based conditioning and CMV reactivation'. Together they form a unique fingerprint.